Search

Press release

ROHACELL® global expansion into Asia: Evonik Industries will build a new plant for the lightweight material in Shanghai

September 19, 2014

Evonik Industries, Essen, Germany, has announced plans to build a new plant for their polymethacrylimide structural foam ROHACELL® in Shanghai, China, scheduled to begin operation in the fourth quarter of 2015.

"Our investment in Shanghai reflects a strategic decision to bring our products closer to the customer, as well as our continued commitment to a region that is a key growth market,” said Dr. Joachim Leluschko, Head of High Performance Polymers Business Line at Evonik.

Currently two plants - in Darmstadt, Germany and Mobile, Alabama, USA – supply customers in Asia. The new facility will be located in Evonik’s Multi-User Site China (MUSC) in Shanghai Chemical Industry Park (SCIP).

The lightweight material ROHACELL® is already being used in Asia’s aviation industry, including the regional jet ARJ21-700 and also the prototype of China’s first large commercial airliner C919 that is scheduled to enter commercial service in 2018.

ROHACELL® high performance foam cores are ideal for the growing advanced composites industry and are enjoying increasing worldwide demand in not only the aviation industry, but also in automotive, electronics, medical technology and sporting goods.

Downloads

Linked Files

ROHACELL® structural foam is an ideal material for lightweight design and long-lasting durability.

ROHACELL® structural foam is an ideal material for lightweight design and long-lasting durability.

Download
Contact

Ursula Keil

High Performance Polymers

  • About Evonik

    Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

    Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.